Baxter Receives 510(k) Clearance From FDA For V-Link With VitalShield, New Antimicrobial Intravascular ... ( Technology shown to kill 99.9% of sp...)

Baxter Receives 510(k) Clearance From FDA For V-Link With VitalShield, New Antimicrobial Intravascular Technology

Date:11/9/2007

Technology shown to kill 99.9% of specific common pathogens known to cause

catheter-related blood stream infections, including MRSA

DEERFIELD, Ill., Nov. 9 /PRNewswire-FirstCall/ -- Baxter Healthcare Corporation today announced that it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its V-Link Luer-activated device (LAD) with VitalShield protective coating. V-Link with VitalShield is the first needleless IV connector containing an antimicrobial coating. This new device has been shown to kill 99.9 percent of specific common pathogens (infection- causing microorganisms) known to cause catheter-related blood stream infections, including the highly treatment-resistant bacteria called methicillin-resistant Staphylococcus aureus, or MRSA. The Centers for Disease Control and Prevention (CDC) recently reported that MRSA infections cause an estimated 18,650 deaths per year in the United States (U.S.), which is more deaths in the U.S. per year than HIV/AIDS.

Baxter plans to launch the V-Link device with VitalShield coating in the U.S. beginning in the first half of 2008 and will expand to global markets later in the year.

"We are very pleased to receive market clearance for V-Link with VitalShield, which is the first in a series of new products Baxter's Medication Delivery business will be introducing over the next year to help reduce risks associated with IV therapy. This innovative technology represents the latest achievement in Baxter's long-standing history of bringing clinical practice-changing IV systems to market," said Camille Farhat, general manager of Global Infusion Systems, part of Baxter's Medication Delivery business. "We believe this technology will provide healthcare professionals with a greater ability to combat pathogens and make healthcare facilities safer environments for patients and clinicians."

"Catheter-related blood stream infections are a daunting challenge for the global healthc
'/>"/>

SOURCE Baxter Healthcare Corporation
Copyright©2007 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2 3 4
Related biology technology :

1. Baxter to Launch GARDian(TM), a Groundbreaking Initiative That Helps Provide Continued Access to GAMMAGARD for Current Patients
2. Baxter and Halozyme Announce Collaboration for Development of Subcutaneous GAMMAGARD LIQUID(TM) Administration Using Enhanze(TM) Technology
3. Baxter Named to Dow Jones Sustainability Index for Ninth Consecutive Year
4. Baxter and Novation Sign Multi-Year Contract Extension Valued at Over $200 Million for Medication Delivery Products
5. Baxter Adds Recombinant Protein to Specialty Therapeutics Portfolio
6. Baxter Kidney Patient Education Program Celebrates Tenth Anniversary
7. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
8. Ciphergen Biosystems Receives Noncompliance Letter From The Nasdaq Stock Market
9. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
10. Anesiva Receives FDA Approval for Zingo(TM), a New, Innovative Product to Reduce Pain Associated with Needle Insertion Procedures in Children
11. IsoTis Receives FDA Clearance for Accell Family of Products

Post Your Comments:

(Date:2/9/2010)... /PRNewswire-Asia-FirstCall/ -- Tianyin,Pharmaceutical Co., Inc., (NYSE Amex: ... traditional Chinese medicine ("TCM") and Western Pharmaceuticals,based in ... expects operational benefits,from the recently published Guide to ... by the Chinese government. ,, ... Chinese National Development and Reform,Commission, the Ministry of ...

(Date:2/9/2010)... 9 United Therapeutics Corporation (Nasdaq: ... release its fourth quarter and annual 2009 financial ... 16, 2010 . ,, United Therapeutics will host ... 2010 , at 9:00 a.m. Eastern Time ... with international callers dialing 1-719-325-2204. A rebroadcast of ...

(Date:2/9/2010)... Feb. 9 /PRNewswire-Asia-FirstCall/ -- NeoStem, Inc.,(NYSE Amex: ... international,biopharmaceutical company with operations in the U.S. and ... collection network has expanded into the southwestern,region of ... group at Westlake,Orthopaedics Spine & Sports ("Westlake") in ... on,track to achieve its target of 10 collection ...

(Date:2/8/2010)... -- Tianyin,Pharmaceutical Co., Inc., (NYSE Alternext: TPI), a manufacturer ... Chengdu, China ,today announced fiscal results for its ... , -- Q2 2010 Revenue Increased ... 24.8% to $2.6 Million with ... -- Cash and Equivalents of $19.9 Million ...

[0] Tianyin Pharmaceutical Co., Inc. Expects to Benefit from the Recently Published Guide to Pricing Reform for Medicine and Medical Services [0] United Therapeutics Corporation to Announce Fourth Quarter and Annual 2009 Financial Results Before Market Open on Tuesday, February 16, 2010 [0] Busy Southwestern Orthopedic Practice Joins the NeoStem Stem Cell Collection Network [0] Tianyin Pharmaceutical Co., Inc. Announces Record Second Quarter 2010 Financial Results

... DIEGO, Nov. 2 Favrille, Inc. (Nasdaq:,FVRL) announced ... with primarily institutional investors to sell up to ... purchase up to 4,449,910 shares,of its common stock ... placement agent fees and estimated offering expenses, in ...

... N.J., Nov. 2 SyntheMed, Inc. (OTC,Bulletin Board: SYMD), ... anti-adhesion and drug delivery products,announced today that Robert P. ... 9th Annual Healthcare Conference on November 5, 2007 at,5:05 ... New York City. Mr. Hickey,will present a company overview. ...

... Delft University of Technologys Kavli Institute of Nanoscience and ... succeeded in controlling the spin of a single electron ... for a much simpler realization of the building blocks ... publish their work in Science Express on Thursday 1 ...

Other Biology Technology:Favrille Announces $21.1 Million Registered Direct Offering 2 Favrille Announces $21.1 Million Registered Direct Offering 3 Delft University of Technology rotates electron spin with electric field 2

Favrille Announces $21.1 Million Registered Direct Offering SyntheMed to Present at the Acumen BioFin Conference Delft University of Technology rotates electron spin with electric field

(Date:2/8/2010)... tobacco smoke that clings to virtually all surfaces ... with the common indoor air pollutant nitrous acid ... hazard was revealed in a multi-institutional study led ... (Berkeley Lab). , "The burning of tobacco releases ... adsorbs strongly onto indoor surfaces, such as walls, ...

(Date:2/8/2010)... Calif.) Advanced maternal age is linked to a ... regardless of the father,s age, according to an exhaustive ... by UC Davis Health System researchers. Advanced paternal age ... father is older and the mother is under 30, ... February issue of the journal Autism Research, ...

(Date:2/7/2010)... the National Cancer Institute (NCI) have found that the ... cancer among women without a personal history of breast ... the risk of developing breast cancer in women who ... of this survey are published in the February issue ... journal of the American Association for Cancer Research. ...

Breaking Biology News(10 mins):Study reveals new details on the dangers of third-hand smoke 2 Study reveals new details on the dangers of third-hand smoke 3 Study reveals new details on the dangers of third-hand smoke 4 UC Davis study confirms link between advanced maternal age and autism 2 UC Davis study confirms link between advanced maternal age and autism 3 UC Davis study confirms link between advanced maternal age and autism 4 Few women take tamoxifen to prevent breast cancer 2 GestureTek Unveils The CUBE V3 Portable Plug and Play Interactive Projection Display System for Advertising and Exhibits 11168 1 GestureTek Unveils The CUBE V3 Portable Plug and Play Interactive Projection Display System for Advertising and Exhibits 11168 2 GestureTek Unveils The CUBE V3 Portable Plug and Play Interactive Projection Display System for Advertising and Exhibits 11168 3 CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 11166 1 CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 11166 2 CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 11166 3 CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 11166 4 IgeaCare Solutions Inc Emerges Under New Leadership and Funding 11164 1 IgeaCare Solutions Inc Emerges Under New Leadership and Funding 11164 2

[0] Study reveals new details on the dangers of third-hand smoke [0] UC Davis study confirms link between advanced maternal age and autism [0] Few women take tamoxifen to prevent breast cancer

... husband and father is not enough to keep an avian ... in the Galapagos Islands off the coast of Ecuador. , ... chick, according to a Wake Forest University study scheduled for ... Biological Sciences June 13. , This is surprising because ...

... of papers that promise to reshape our understanding of ... traditional view of our genetic blueprint as a tidy ... network in which genes, along with regulatory elements and ... for proteins, interact in overlapping ways not yet fully ...

... with brains untouched by a pathological process, however, an ... with the number of different disease processes present in ... was funded by the National Institute on Aging (NIA), ... at the Rush Alzheimer’s Disease Center at Rush University ...

Other Biology News:Study investigates 'divorce' among Galapagos seabirds 2 New findings challenge established views on human genome 2 New findings challenge established views on human genome 3 New findings challenge established views on human genome 4 Study finds mix of disease processes at work in brains of most people with dementia 2

Study investigates 'divorce' among Galapagos seabirds New findings challenge established views on human genome Study finds mix of disease processes at work in brains of most people with dementia

...

Request Info...

UNIVERSAL SCORECARD DNA, 1 EA. * Category: Reagents/Consumables....

mitochondrial proteins (human heart) for SDS-polyacrylamide gel electrophoresis *2 mg/mL*...

Biology Products:

Mouse MMP-9 (Total) ELISpot Kit from R&D Systems Basement Membrane Extract Reduced Growth Factor from R&D Systems UNIVERSAL SCORECARD DNA from GE Healthcare, formerly Amersham Biosciences mitochondrial proteins (human heart) for SDS-polyacrylamide gel electrophoresis from Molecular Probes (Invitrogen)

Baxter Receives 510(k) Clearance From FDA For V-Link With VitalShield, New Antimicrobial Intravascular ...( Technology shown to kill 99.9% of sp...)